US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 90.490
- +0.300+0.33%
Close Nov 25 16:00 ET
- 90.670
- +0.180+0.20%
Post 20:02 ET
112.77BMarket Cap1005.44P/E (TTM)
91.365High89.500Low10.75MVolume90.750Open90.190Pre Close971.53MTurnover0.87%Turnover Ratio20.11P/E (Static)1.25BShares98.90052wk High6.10P/B112.55BFloat Cap60.75052wk Low3.06Dividend TTM1.24BShs Float98.900Historical High3.38%Div YieldTTM2.07%Amplitude0.405Historical Low90.339Avg Price1Lot Size
About Gilead Sciences Company
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Company Profile
SymbolGILD
Company NameGilead Sciences
Listing DateJan 22, 1992
Issue Price15.00
Founded1987
CEOMr. Daniel P. O'Day
MarketNASDAQ
Employees18000
Fiscal Year Ends12-31
Address333 Lakeside Drive
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-574-3000
Websitehttp://www.gilead.com
Company Executives
- Name
- Position
- Salary
- Daniel O’Day
- Chairman of the Board and Chief Executive Officer
- --
- Daniel P. O'Day
- Chairman of the Board and Chief Executive Officer
- 22.61M
- Sandra Patterson
- Senior Vice President, Assistant Controller and Chief Accounting Officer
- --
- Dr. Merdad V. Parsey, M.D.,PhD
- Chief Medical Officer
- 8.39M
- Johanna Mercier
- Chief Commercial Officer
- 8.59M
- Andrew D. Dickinson
- Chief Financial Officer
- 8.11M
- Deborah H. Telman
- Executive Vice President, Corporate Affairs, Corporate Secretary and General Counsel
- 5.27M
- Dr. Ted W. Love, M.D.
- Director
- --
- Kelly Anne Kramer
- Independent Director
- 434.92K
- Anthony Welters
- Independent Director
- 444.92K
- Javier J. Rodriguez
- Independent Director
- 399.92K
- Harish Manwani
- Independent Director
- 414.92K
- Jeffrey A. Bluestone
- Independent Director
- 409.92K
- Dr. Jacqueline K. Barton, PhD
- Independent Director
- 429.92K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 429.92K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
